AUB
VERV

Atlantic Union Bankshares’s Verve Therapeutics VERV Stock Holding History

Atlantic Union Bankshares’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,200
Closed -$13.5K – 1695
2025
Q2 		$13.5K Buy
+1,200
New +$6.84K ﹤0.01% 878

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Atlantic Union Bankshares's VERV Position: Q3 2025 in Review

Atlantic Union Bankshares sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 1,200 shares — an estimated $13.5K sold.

Atlantic Union Bankshares first reported a position in VERV in Q2 2025 and held it in 1 quarter. The position peaked at $13.5K in Q2 2025. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Atlantic Union Bankshares reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Atlantic Union Bankshares sold 1,200 Verve Therapeutics shares in Q3 2025, an estimated $13.5K.
  • Atlantic Union Bankshares first reported a position in Verve Therapeutics in Q2 2025 and held it in 1 quarter.
  • Atlantic Union Bankshares's Verve Therapeutics position peaked at $13.5K in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Atlantic Union Bankshares's 13F filing for Q3 2025, filed 4 Nov 2025.